Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591/TMV-083, in healthy adults: resuts of a randomized, placebo controlled Phase I study

Authors: Odile Launay, Cécile Artaud, Marie Lachâtre, Mohand Ait-Ahmed, Jelle Klein, Liem Binh Luong Nguyen, Christine Durier, Bastiaan Jansen, Yvonne Tomberger, Nathalie Jolly, Anna Grossmann, Houda Tabbal, Jérémy Brunet, Marion Gransagne, Zaineb Choucha, Damien Batalie, Ana Delgado, Matthias Müllner, Roland Tschismarov, Pieter-Jan Berghmans, Annette Martin, Katrin Ramsauer, Nicolas Escriou, Christiane Gerke DOI: 10.1016/j.ebiom.2021.103810

BIOASTER wishes you a healthy & prosperous new year!

BIOASTER wishes you a healthy & prosperous new year! “When the going gets tough, the tough get going” Thanks to our partners, founding members and teams for keeping on building...

BIOASTER is glad to be part of Cynbiome

BIOASTER is glad to be part of Cynbiome, the 1st preclinical excellence research network dedicated to the #microbiome research applied to infectiousdiseases. Together with our partners, we will capitalize on...

New Publication from REALISM Project in Frontier Immunol.

New publication from REALISM collaborative project in Frontiers in Immunology about Herpes DNAemia & TTV Viraemia in Intenisve Care unit entilted: “Herpes DNAemia and TTV Viraemia in Intensive Care Unit...